Skip to main content
    J

    Janux Therapeutics Inc (JANX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $10.71
    -0.21 (-1.92%)

    Market Cap: $695.65M

    Last updated: Nov 17, 2026 at 4:18 PM ET

    Janux Therapeutics Inc (JANX) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Janux Therapeutics (JANX) has a latest price of $10.71 on Nov 17, 2026. Its price fell 63.4% over the past 12 months. The month-end price fell 28.3% over the 5 years through Oct 2026, a compound annual decline of 6.4%.

    Price Chart

    From Jun 2021 to Oct 2026, its highest month-end close was $57.00 in Apr 2024 and its lowest $6.42 in Oct 2023, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart JANX with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for JANX.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 38.9%, and over 6 months it fell 22.4%. The month-end price rose 172.1% over the 3 years through Oct 2026, a compound annual rate of 39.6%.

    PeriodChange
    1 month-36.0%
    3 months-38.9%
    6 months-22.4%
    12 months-63.4%
    12 months, with dividends-63.4%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+172.1%+39.6%
    5 years-28.3%-6.4%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2024, when the price rose 399.0%, and its weakest was 2025, when it fell 74.2%.

    YearCloseChange
    2026 through Oct 2026$17.47+26.6%
    2025$13.80-74.2%
    2024$53.54+399.0%
    2023$10.73-18.5%
    2022$13.17-33.2%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 34.8% below its 50-day average of $16.43 and 30.1% below its 200-day average of $15.33.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$10.71
    50-day average$16.43-34.8%
    200-day average$15.33-30.1%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 84.0%.

    MeasureValue
    1-year beta0.92
    Largest fall, 1 year-69.2%
    Largest fall, 3 years-84.0%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About JANX

    What is JANX's 1-year price change?

    Janux Therapeutics's price fell 63.4% over the past 12 months. With dividends included, the 12-month total return was -63.4%.

    What is JANX's 5-year price change?

    Janux Therapeutics's month-end price fell 28.3% over the 5 years through Oct 2026, a compound annual decline of 6.4%. These figures leave out dividends.

    What is JANX's beta?

    Janux Therapeutics's 1-year beta against the S&P 500 is 0.92, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 69.2%.

    Is the JANX chart free?

    Yes. Advanced Charting for JANX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.